Acadian Asset Management »

4d Molecular Therapeutics In shares owned by Acadian Asset Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $478k 55k 8.68
2025-06-30 $1.2M 331k 3.71
2025-03-31 $1.3M 401k 3.22
2024-12-31 $185k 33k 5.56
2022-09-30 $454k 57k 8.02
2022-06-30 $663k 95k 6.98